Kiora Pharmaceuticals, Inc. Common Stock (KPRX) Stock Price, Quote & AI Analysis

Live KPRX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Kiora Pharmaceuticals, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Kiora Pharmaceuticals, Inc. Common Stock (KPRX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

KPRX
Kiora Pharmaceuticals, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
2.060000
High
2.060000
Low
1.980000
Volume
48,494
VWAP
-
Market Cap
$7,723,663.50
52W Range
$1.76 - $4.18
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 23, 2026 Q4
After Hours
EPS Estimate: $-0.6834
Revenue Estimate: $1,530,000.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Kiora Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Kiora Pharmaceuticals, Inc. Common Stock Overview

Company information

Company Overview

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

Company Details
Market Cap
$7.37M
Shares Outstanding
3,677,940
Weighted Shares Outstanding
3,677,935
CEO
Brian Matthew Strem
Address
169 SAXONY RD., ENCINITAS, CA, 92024
Employees
12
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Kiora Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...